Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith a copy of Corrigendum - 2 to Notice of Extra-ordinary General Meeting of the Company published in the newspapers viz. Business Standard (English) on 6th July, 2021 and in Tarun Bharat (Marathi) on today. MARKSANS PHARMA LTD. - 524404 - Corrigendum - 2 To Notice Of The Extra-Ordinary General Meeting Of The Company
With reference to our letter dated 16th June, 2021 under subject 'Notice of the Extra-Ordinary General Meeting (EGM) of the Company', read with Corrigendum dated 30th June, 2021, the Company has issued a Corrigendum - 2 to EGM Notice, which is enclosed herewith for your record & dissemination. This corrigendum - 2 should be read along with the original EGM Notice dated 15th June, 2021 and with Corrigendum dated 30th June, 2021 which was submitted to the Stock Exchanges. The Corrigendum - 2 to the Notice of the Extra-ordinary General Meeting is also uploaded at the Company's website viz. www.marksanspharma.com. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith a copy of Corrigendum to Notice of Extra-ordinary General Meeting of the Company published today i.e. 2nd July, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers. Marksans Pharma Ltd - 524404 - Corrigendum To Notice Of The Extra-Ordinary General Meeting Of The Company
With reference to our letter dated 16th June, 2021 under subject 'Notice of the Extra-Ordinary General Meeting (EGM) of the Company', the Company has issued a Corrigendum to the shareholders, which is enclosed herewith for your record & dissemination. This corrigendum should be read along with the original EGM Notice dated 15th June, 2021 which was submitted to the Exchange along with the above mentioned letter. The Corrigendum to the NOTICE of the Extra-ordinary General Meeting is also uploaded at the Company's website viz. www.marksanspharma.com. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith copies of Notice given to shareholders regarding transfer of equity shares to the Investor Education and Protection Fund published today i.e. 30th June, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers. MARKSANS PHARMA LTD. - 524404 - Closure of Trading Window
In terms of the Company''s Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed from Thursday, 1st July, 2021 till 48 hours after the declaration of financial results for the quarter ended 30th June, 2021. The date of declaration of financial results will be intimated separately in due course of time. Designated Persons, Employees and other insiders of the Company and/or their immediate relatives shall not trade in the securities of the Company during the aforesaid period of closure of trading window. Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Credit Rating
Intimation of Revision in Credit Ratings of Marksans Pharma Limited by Fitch Group. MARKSANS PHARMA LTD. - 524404 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read alongwith SEBI Circular ClR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2021 issued by Mr. Jinesh Dedhia of Jinesh Dedhia & Associates, Practicing Company Secretaries. MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Marksans Pharma Ltd - 524404 - Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2021
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosures of related party transactions for the half year ended 31st March, 2021. The financial results for the quarter and year ended 31st March, 2021 both standalone and consolidated were published on 31st May, 2021.